Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue	$ 13,911,000	$ 14,789,000
Cost of revenue	3,604,000	4,228,000
Gross profit	10,307,000	10,561,000
Operating expenses:
Research and development	2,657,000	2,324,000
Sales and marketing	7,209,000	6,279,000
General and administrative	7,024,000	5,208,000
Settlement expense		99,000
Total operating expenses	16,890,000	13,910,000
Operating loss from continuing operations	(6,583,000)	(3,349,000)
Other income (expense):
Interest income	619,000	1,200,000
Foreign exchange gains (losses)	963,000	(884,000)
Loss from continuing operations before income taxes	(5,001,000)	(3,033,000)
Income tax benefit (expense) from continuing operations	(209,000)	1,537,000
Loss from continuing operations	(5,210,000)	(1,496,000)
Discontinued operations:
Income from discontinued operations before income taxes	147,000
Income tax expense from discontinued operations	(964,000)
Loss from discontinued operations	(817,000)
Net loss	$ (6,027,000)	$ (1,496,000)
Net loss per ordinary share - basic and diluted:
Loss from continuing operations (in dollars per share)	$ (0.20)	$ (0.06)
Loss from discontinued operations (in dollars per share)	(0.03)
Net loss (in dollars per share)	$ (0.23)	$ (0.06)
Weighted-average shares used to compute net loss per ordinary share - basic and diluted (in shares)	26,140,524	26,515,871